Brazil aims for maturity in device regulation
This article was originally published in SRA
Executive Summary
Brazil's medical device regulatory agency, Anvisa, has launched several new legal instruments and initiatives that should make the $6 billion medtech market at once better regulated and more attractive for medtech manufacturers at home and abroad.